NCT00002238已完成3 期
Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Bayer
- 试验地点
- 46
研究概览
简要总结
To evaluate the safety and efficacy of interferon beta (Betaseron) in AIDS and advanced AIDS related complex (ARC) patients receiving a reduced-dose zidovudine (AZT) regimen.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (46)
Loading locations...
相似试验
已完成
3 期
A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV TreatmentHIV InfectionsNCT00004581Abbott300
进行中（未招募）
3 期
P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 RiskMyeloproliferative NeoplasmPrimary MyelofibrosisNCT06468033PharmaEssentia160
已完成
3 期
Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia VeraPolycythemia VeraNCT01949805AOP Orphan Pharmaceuticals AG257
已完成
3 期
Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C PatientsChronic Hepatitis CNCT01581398Xiamen Amoytop Biotech Co., Ltd.770
已完成
3 期
Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BChronic Hepatitis BNCT01760122Xiamen Amoytop Biotech Co., Ltd.820